Core Elements of our Equity Story

We aim to increase Group sales by a multi-year average of 10%. We expect 6% to result from organic growth and about 4% from acquisitions. But we do not want this dynamic development to be at the expense of profitability. The operating earnings (EBITDA) should be at a range of 18% to 20% of sales and thus continue to be significantly higher than those of comparable stock market listed speciality chemicals companies.

Important pillars for our future growth include our excellent positions worldwide in rapidly growing niche markets, the high specialization of our products and services, our extra-ordinary ability to innovate, and the global presence of all our divisions. At the same time, on account of our diversified product portfolio and our balanced regional presence, there are no essential dependencies on individual end consumer markets, customers, suppliers, raw materials, or regional economic and currency developments.

Our past development shows that we can reach challenging targets. In the last ten years, our specialty chemicals sales posted an average yearly growth of 12%. In the same period, the EBITDA margin was always at a level of 18% or higher. Value-creating acquisitions played an important part in the sales increase and helped to ensure our high profitability. An active portfolio management should continue to help boost the corporate value in the future.

In comparison to other specialty chemicals companies, at ALTANA there is a balanced relationship between attractive growth coupled with consistently high profitability and a moderate risk profile. As a result, the company occupies a distinctive position from a capital market perspective.